Literature DB >> 29255092

Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation.

Tomohiro Tanaka1, Yue Zhou1,2, Tatsuhiko Ozawa3, Ryuya Okizono1, Ayako Banba1, Tomohiro Yamamura1, Eiji Oga1, Atsushi Muraguchi3, Hiroaki Sakurai4.   

Abstract

The canonical description of transmembrane receptor function is initial binding of ligand, followed by initiation of intracellular signaling and then internalization en route to degradation or recycling to the cell surface. It is known that low concentrations of extracellular ligand lead to a higher proportion of receptor that is recycled and that non-canonical mechanisms of receptor activation, including phosphorylation by the kinase p38, can induce internalization and recycling. However, no connections have been made between these pathways; i.e. it has yet to be established what happens to unbound receptors following stimulation with ligand. Here we demonstrate that a minimal level of activation of epidermal growth factor receptor (EGFR) tyrosine kinase by low levels of ligand is sufficient to fully activate downstream mitogen-activated protein kinase (MAPK) pathways, with most of the remaining unbound EGFR molecules being efficiently phosphorylated at intracellular serine/threonine residues by activated mitogen-activated protein kinase. This non-canonical, p38-mediated phosphorylation of the C-tail of EGFR, near Ser-1015, induces the clathrin-mediated endocytosis of the unliganded EGFR monomers, which occurs slightly later than the canonical endocytosis of ligand-bound EGFR dimers via tyrosine autophosphorylation. EGFR endocytosed via the non-canonical pathway is largely recycled back to the plasma membrane as functional receptors, whereas p38-independent populations are mainly sorted for lysosomal degradation. Moreover, ligand concentrations balance these endocytic trafficking pathways. These results demonstrate that ligand-activated EGFR signaling controls unliganded receptors through feedback phosphorylation, identifying a dual-mode regulation of the endocytic trafficking dynamics of EGFR.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  TNF-α; clathrin; endocytosis; epidermal growth factor receptor (EGFR); p38 MAPK; tumor necrosis factor

Mesh:

Substances:

Year:  2017        PMID: 29255092      PMCID: PMC5818182          DOI: 10.1074/jbc.M117.811299

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Improved Phos-tag SDS-PAGE under neutral pH conditions for advanced protein phosphorylation profiling.

Authors:  Eiji Kinoshita; Emiko Kinoshita-Kikuta
Journal:  Proteomics       Date:  2010-12-14       Impact factor: 3.984

2.  Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress.

Authors:  Jiefei Tong; Paul Taylor; Michael F Moran
Journal:  Mol Cell Proteomics       Date:  2014-05-05       Impact factor: 5.911

Review 3.  Feedback regulation of EGFR signalling: decision making by early and delayed loops.

Authors:  Roi Avraham; Yosef Yarden
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02       Impact factor: 94.444

4.  A kinase-independent role for EGF receptor in autophagy initiation.

Authors:  Xiaojun Tan; Narendra Thapa; Yue Sun; Richard A Anderson
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

5.  Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-alpha through the TAK1-p38 signaling pathway.

Authors:  Pattama Singhirunnusorn; Yoko Ueno; Mitsuhiro Matsuo; Shunsuke Suzuki; Ikuo Saiki; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2007-02-27       Impact factor: 5.157

6.  Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction.

Authors:  A R French; D K Tadaki; S K Niyogi; D A Lauffenburger
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

7.  Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.

Authors:  Qingxiang Sun; Rebecca A Jackson; Cherlyn Ng; Graeme R Guy; J Sivaraman
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

8.  Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR trafficking.

Authors:  Chiara Francavilla; Moreno Papetti; Kristoffer T G Rigbolt; Anna-Kathrine Pedersen; Jon O Sigurdsson; Giuseppe Cazzamali; Gopal Karemore; Blagoy Blagoev; Jesper V Olsen
Journal:  Nat Struct Mol Biol       Date:  2016-05-02       Impact factor: 15.369

9.  Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.

Authors:  Yue Zhou; Naoki Yamada; Tomohiro Tanaka; Takashi Hori; Satoru Yokoyama; Yoshihiro Hayakawa; Seiji Yano; Junya Fukuoka; Keiichi Koizumi; Ikuo Saiki; Hiroaki Sakurai
Journal:  Nat Commun       Date:  2015-07-09       Impact factor: 14.919

Review 10.  EGF receptor trafficking: consequences for signaling and cancer.

Authors:  Alejandra Tomas; Clare E Futter; Emily R Eden
Journal:  Trends Cell Biol       Date:  2013-11-29       Impact factor: 20.808

View more
  16 in total

1.  Cisplatin-induced non-canonical endocytosis of EGFR via p38 phosphorylation of the C-terminal region containing Ser-1015 in non-small cell lung cancer cells.

Authors:  Tomohiro Tanaka; Tatsuhiko Ozawa; Eiji Oga; Atsushi Muraguchi; Hiroaki Sakurai
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

2.  Time-resolved proximity labeling of protein networks associated with ligand-activated EGFR.

Authors:  Mireia Perez Verdaguer; Tian Zhang; Sachin Surve; Joao A Paulo; Callen Wallace; Simon C Watkins; Steven P Gygi; Alexander Sorkin
Journal:  Cell Rep       Date:  2022-06-14       Impact factor: 9.995

3.  The Candida albicans toxin candidalysin mediates distinct epithelial inflammatory responses through p38 and EGFR-ERK pathways.

Authors:  Spyridoula-Angeliki Nikou; Chunsheng Zhou; James S Griffiths; Natalia K Kotowicz; Bianca M Coleman; Mary J Green; David L Moyes; Sarah L Gaffen; Julian R Naglik; Peter J Parker
Journal:  Sci Signal       Date:  2022-04-05       Impact factor: 8.192

4.  Mechanism of p38 MAPK-induced EGFR endocytosis and its crosstalk with ligand-induced pathways.

Authors:  Mireia Perez Verdaguer; Tian Zhang; Joao A Paulo; Steven Gygi; Simon C Watkins; Hiroaki Sakurai; Alexander Sorkin
Journal:  J Cell Biol       Date:  2021-05-25       Impact factor: 10.539

5.  The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients.

Authors:  Kazuhisa Furue; Takamichi Ito; Yuka Tanaka; Akiko Hashimoto-Hachiya; Masaki Takemura; Maho Murata; Makiko Kido-Nakahara; Gaku Tsuji; Takeshi Nakahara; Masutaka Furue
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

6.  Increase of the Intracellular Zinc Concentration Leads to an Activation and Internalisation of the Epidermal Growth Factor Receptor in A549 Cells.

Authors:  Lisa-Marie Barth; Lothar Rink; Inga Wessels
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

7.  Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth.

Authors:  Nan Yao; Chen-Ran Wang; Ming-Qun Liu; Ying-Jie Li; Wei-Min Chen; Zheng-Qiu Li; Qi Qi; Jin-Jian Lu; Chun-Lin Fan; Min-Feng Chen; Ming Qi; Xiao-Bo Li; Jian Hong; Dong-Mei Zhang; Wen-Cai Ye
Journal:  Signal Transduct Target Ther       Date:  2020-10-09

8.  Clathrin-mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild-type EGFR non-small cell lung cancer.

Authors:  Boyeon Kim; Young Soo Park; Jae Sook Sung; Jong Won Lee; Saet Byeol Lee; Yeul Hong Kim
Journal:  Cancer Med       Date:  2020-12-12       Impact factor: 4.452

Review 9.  Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.

Authors:  Agnieszka Rybarczyk-Kasiuchnicz; Rodryg Ramlau; Katarzyna Stencel
Journal:  Int J Mol Sci       Date:  2021-01-08       Impact factor: 5.923

Review 10.  Receptor Tyrosine Kinase Ubiquitination and De-Ubiquitination in Signal Transduction and Receptor Trafficking.

Authors:  William R Critchley; Caroline Pellet-Many; Benjamin Ringham-Terry; Michael A Harrison; Ian C Zachary; Sreenivasan Ponnambalam
Journal:  Cells       Date:  2018-03-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.